Triple GH Optimization Blend
Triple combination for comprehensive GH optimization.
This advanced peptide blend synergistically combines Ipamorelin’s selective GH secretion, CJC-1295’s extended pituitary stimulation, and IGF-LR3’s direct anabolic signaling to create a comprehensive, multi-pathway approach to growth hormone optimization and tissue regeneration.
3x
Synergistic Pathways
Extended
GH Elevation
Direct
Anabolic Action
24/7
Tissue Support
Blend Components
This comprehensive blend combines three complementary peptides for maximum growth hormone optimization through multiple synergistic pathways.
10mg per dose
Primary Benefits
Provides targeted, clean growth hormone stimulation through ghrelin receptor activation without affecting cortisol or prolactin levels.
5mg per dose
Primary Benefits
Delivers sustained growth hormone-releasing hormone activity with extended half-life for prolonged pituitary stimulation and consistent GH levels.
1mg per dose
Primary Benefits
Provides direct anabolic signaling through IGF receptors, promoting muscle protein synthesis, tissue repair, and metabolic optimization independently of GH.
The Science
The IPA/CJC/IGF blend represents the pinnacle of growth hormone optimization, combining three complementary peptides that work through distinct yet synergistic pathways to maximize both GH production and downstream anabolic signaling.
Ipamorelin provides selective, clean GH stimulation through ghrelin receptor activation. CJC-1295 extends this effect with sustained GHRH analog activity, maintaining elevated GH levels over extended periods. IGF-LR3 completes the stack by directly activating IGF receptors, ensuring robust anabolic tissue response independent of endogenous GH fluctuations.
Together, these three peptides create a comprehensive approach: upstream pituitary stimulation (IPA + CJC) combined with downstream receptor activation (IGF-LR3). This dual-level strategy optimizes both hormone production and tissue response for maximum therapeutic benefit.
Book a Consultation
How It Works
The IPA/CJC/IGF blend works through three complementary mechanisms to comprehensively optimize growth hormone signaling at multiple levels.
Ipamorelin binds to ghrelin receptors on pituitary somatotrophs, triggering immediate, targeted growth hormone release without affecting cortisol or prolactin.
CJC-1295’s extended half-life maintains prolonged growth hormone-releasing hormone receptor stimulation, creating sustained GH elevation over days rather than hours.
IGF-LR3 directly activates IGF-1 receptors in muscle, bone, and metabolic tissues, promoting protein synthesis and tissue repair independent of circulating GH levels.
Clinical Benefits
Triple-pathway stimulation promotes superior muscle protein synthesis through both upstream GH elevation and direct IGF receptor activation in skeletal muscle.
Sustained GH elevation from CJC combined with IGF’s metabolic effects creates powerful lipolytic signaling for improved body composition.
Multi-level growth factor signaling accelerates tissue repair, reduces inflammation, and shortens recovery time after training or injury.
CJC-1295’s prolonged half-life maintains elevated GH levels between doses, creating more stable hormone patterns and consistent therapeutic effects.
Ipamorelin’s selective GH stimulation supports natural sleep architecture and recovery, enhancing the restorative phases of rest.
Combined GH and IGF signaling promotes osteoblast activity and collagen synthesis, supporting skeletal health and fracture resistance.
Your Journey
Our medical team guides you through every stepfrom initial consultation to ongoing optimization.
Comprehensive health assessment and discussion of your goals with our peptide therapy specialists.
Baseline hormone panels and metabolic markers to establish your current status and determine candidacy.
Personalized dosing and administration schedule designed for your specific physiology and objectives.
Regular monitoring, dose adjustments, and medical guidance throughout your therapy journey.
Safety & Candidacy
The IPA/CJC/IGF blend is administered under medical supervision to patients who meet specific health criteria. Our physicians carefully evaluate candidacy through comprehensive assessment.
3
Synergistic peptides working through complementary pathways for comprehensive GH optimization
Medical
Physician-guided therapy with regular monitoring and dose optimization throughout treatment
Questions
The IPA/CJC/IGF blend works through three distinct pathways simultaneously. Ipamorelin provides immediate GH release, CJC-1295 sustains elevation over days, and IGF-LR3 directly activates tissue receptors. This multi-level approach creates more comprehensive hormone optimization than any single peptide alone.
The blend is administered via subcutaneous injection, typically before bed to align with natural GH secretion patterns. Your physician will provide specific dosing instructions and injection technique guidance based on your individual protocol.
Many patients report improved sleep quality and recovery within the first 1-2 weeks. Body composition changes typically become noticeable at 4-6 weeks, with progressive improvements in muscle mass, fat loss, and overall vitality continuing through 3-6 months of consistent therapy.
Most patients tolerate the blend well. Potential side effects may include temporary water retention, mild joint discomfort, or increased appetite. These effects are typically mild and often resolve with dose adjustment. Our medical team monitors you closely to optimize both efficacy and tolerability.
Treatment duration varies based on individual goals and response. Many patients benefit from 3-6 month cycles followed by periodic breaks. Your physician will create a personalized treatment plan and adjust timing based on your laboratory results and clinical response.
The IPA/CJC/IGF blend can be integrated into comprehensive hormone optimization programs. Our physicians will evaluate potential interactions with your current medications or supplements and design a coordinated treatment plan that maximizes benefits while maintaining safety.
Contraindications include active or recent cancer, uncontrolled diabetes, severe diabetic retinopathy, and pregnancy. A thorough medical evaluation and screening are required to determine candidacy. Our physicians will discuss your complete health history during consultation.
Get Started
Schedule a consultation with our medical team to learn if IPA/CJC/IGF peptide therapy is right for your wellness journey.
"*" indicates required fields
Or call us directly: +1 213-325-3373
*These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease. The IPA/CJC/IGF blend is available only through licensed physicians for patients with clinical need. Peptide therapy requires medical supervision and is contraindicated in patients with active malignancy, uncontrolled diabetes, or diabetic retinopathy. Individual results may vary. A consultation with our medical team and baseline laboratory testing are required to determine if this therapy is appropriate for you.
